Literature DB >> 8899707

An elongation factor Tu (EF-Tu) resistant to the EF-Tu inhibitor GE2270 in the producing organism Planobispora rosea.

M Sosio1, G Amati, C Cappellano, E Sarubbi, F Monti, S Donadio.   

Abstract

Using a cell-free protein-synthesis system, we have established that the elongation factor (EF) Tu (EF-Tu) of the actinomycete Planobispora rosea, the producer of the thiazolyl peptide GE2270, a specific EF-Tu inhibitor, is highly resistant to its own antibiotic, while it is completely inhibited by kirromycin, which is another inhibitor of this factor. P. rosea was found to possess a single tuf gene, located between fus and rpsJ, encoding other components of the protein-synthesis machinery. The P. rosea tuf gene was expressed as a translational fusion to malE in Escherichia coli, and the resulting EF-Tu with an N-terminal Gly-Met extension was able to promote poly(U)-directed poly(Phe) synthesis in cell-free systems. This activity was not affected by GE2270, and the recombinant protein was incapable of binding the antibiotic, indicating that the P. rosea EF-Tu is intrinsically resistant to this inhibitor. Inspection of the translated tuf sequence revealed a number of amino acid substitutions in highly conserved positions. These residues, which are likely to be involved in conferring GE2270 resistance, map in EF-Tu domain II, as do the only two known mutations conferring resistance to this class of thiazolyl peptides in Bacillus subtilis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8899707     DOI: 10.1111/j.1365-2958.1996.tb02654.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  8 in total

Review 1.  Avoidance of suicide in antibiotic-producing microbes.

Authors:  Eric Cundliffe; Arnold L Demain
Journal:  J Ind Microbiol Biotechnol       Date:  2010-05-06       Impact factor: 3.346

2.  A Derivative of the Thiopeptide GE2270A Highly Selective against Propionibacterium acnes.

Authors:  Attilio Fabbretti; Cheng-Guang He; Eleonora Gaspari; Sonia Maffioli; Letizia Brandi; Roberto Spurio; Margherita Sosio; Daniela Jabes; Stefano Donadio
Journal:  Antimicrob Agents Chemother       Date:  2015-05-18       Impact factor: 5.191

3.  Elongation factor Tu3 (EF-Tu3) from the kirromycin producer Streptomyces ramocissimus Is resistant to three classes of EF-Tu-specific inhibitors.

Authors:  Lian N Olsthoorn-Tieleman; Robert-Jan T S Palstra; Gilles P van Wezel; Mervyn J Bibb; Cornelis W A Pleij
Journal:  J Bacteriol       Date:  2007-03-02       Impact factor: 3.490

4.  Codon randomization for rapid exploration of chemical space in thiopeptide antibiotic variants.

Authors:  Travis S Young; Pieter C Dorrestein; Christopher T Walsh
Journal:  Chem Biol       Date:  2012-12-21

Review 5.  YcaO-Dependent Posttranslational Amide Activation: Biosynthesis, Structure, and Function.

Authors:  Brandon J Burkhart; Christopher J Schwalen; Greg Mann; James H Naismith; Douglas A Mitchell
Journal:  Chem Rev       Date:  2017-03-03       Impact factor: 60.622

6.  A Genomic, Transcriptomic and Proteomic Look at the GE2270 Producer Planobispora rosea, an Uncommon Actinomycete.

Authors:  Arianna Tocchetti; Roberta Bordoni; Giuseppe Gallo; Luca Petiti; Giorgio Corti; Silke Alt; Joao C S Cruz; Anna Maria Salzano; Andrea Scaloni; Anna Maria Puglia; Gianluca De Bellis; Clelia Peano; Stefano Donadio; Margherita Sosio
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

7.  The Antibiotic Resistant Target Seeker (ARTS), an exploration engine for antibiotic cluster prioritization and novel drug target discovery.

Authors:  Mohammad Alanjary; Brent Kronmiller; Martina Adamek; Kai Blin; Tilmann Weber; Daniel Huson; Benjamin Philmus; Nadine Ziemert
Journal:  Nucleic Acids Res       Date:  2017-07-03       Impact factor: 16.971

8.  Heterologous expression of the thiopeptide antibiotic GE2270 from Planobispora rosea ATCC 53733 in Streptomyces coelicolor requires deletion of ribosomal genes from the expression construct.

Authors:  Katrin Flinspach; Claudia Kapitzke; Arianna Tocchetti; Margherita Sosio; Alexander K Apel
Journal:  PLoS One       Date:  2014-03-05       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.